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I.  Abstract 
 
Cell transfection is an exemplary tool in protein analysis and examining transcription factor activity.              
While general procedures are commonly followed, each cell line requires slight differentiation in             
pBABE/PEI JET ratios and initial cell count for optimal transfection results. This research focusses              
on determining a successful procedure for TOV-112 carcinoma cells for future work with             
2-methoxyestradiol and NFkB. 2-methoxyestradiol is an angiogenesis inhibitor believed to          
decrease inflammatory processes. NFkB promoter controls the luciferase gene on the MetLuc            
plasmid and is pro-inflammatory. The objective of this experiment is to modify the variables until               
successful results at 24 and 48 hours are observed. Four experimental transfections were conducted              
during the three months of research, which analyzed the effectiveness of high and low              
pBABE/PEI JET ratios and increased vs. decreased initial plate seeding. Results show that optimal              
TOV-112 transfection occurs with a 1:2 pBABE/PEI JET ratio and an initial cell count of around                
3x10^5 cells/mg. Future work will hope to emphasize this conclusion and continue with the              
overarching  NFkB  ovarian  cancer  research,  which  aims  to  reduce  the  cases  of  lethal  occurrences.  
 
II.  Introduction 
 
Cell transfection, the introduction of foreign nucleic acids on eukaryotic cells for the purpose of               
genetic uptake and experimental observance, is a useful experimental tool to measure activity of              
various proteins and transcription factors,  [6]. While similar in technique, diversified kinds of cells              
require slight manipulations in the overall procedure. TOV-112 are human endometrial histotype            
carcinoma cells known to cause ovarian cancer,  [8] . This form of cancer has an excessively high                
mortality rate due to late-stage diagnostic findings. With no modern mechanisms for early             
diagnosis, ovarian carcinoma female lethality is fifth in cancer deaths,  [2, 4-5] . In successful              
ovarian cancer transfections, there are great potentials in advancement for ovarian cancer studies             
and with deeper information, earler detection may be possible. In this form of cell transfection,               
TOV-112 cells are grown in 90% Dulbecco's Modified Eagle Medium, 10% Fetal Bovine Serum,              
and 0.5% Penicillin streptomycin. DMEM is rich in glucose and other growth nutrients, which              
allow for optimal and healthy cell growth,  [3] . TOV-112 cells double in about a period of 22 hours,                  
which requires greater upkeep and nutrient availability. FBS and Penstrep also ensure proper             
growth where FBS has increased growth serum and Penstrep is antibacterial. Penstrep is later              
removed from the growth medium to establish limited barriers for genetic uptake. The ovarian              
cancer cells are transfected with pBABE plasmid. This carries the gene for the Green Fluorescent               
Protein (GFP). When the plasmid is translated, transfected cells can be visualized by fluorescent              
microscopy,  [7] . Image 1.0 below shows the pBABE plasmid map that contains the genetic              
material for GFP translation. Ampicillin-resistant genetic material with the pBABE plasmid was            
amplified via Polymerase Chain Reaction (PCR) and the pBABE plasmid was extracted and             
isolated. Since transfection, in most cases, would be lethal to the delicate cells, Opti-MEM media               
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buffers the solution with HEPES and Sodium Bicarbonate,  [3] . PEI-JET is used for efficient gene               
delivery. The purpose of this research is to find an optimal transfection procedure for TOV-112               
cells by varying the pBABE and PEI JET ratios and manipulating the original cell count at the                 
beginning of the transfection. This determination leads into future research with Metridia            
Luciferase (MetLuc) transfection and 2-methoxyestradiol introduction to see if there is a decrease             
in luciferase protein activation proportional to Nuclear Factor kappa Beta (NFkB) activity. MetLuc             
is a plasmid that contains the genetic coding for luciferase. The MetLuc gene is controlled by the                 
NFkB promoter. NFkB is a transcription factor that promotes angiogenesis in the presence of              
ovarian cancer. It participates in inflammatory processes and since ovulation is pro-inflammatory, it             
is believed to be involved with ovarian cancer cases. Determining if 2-methoxyestradiol attracts             
anti-inflammatory processes in-vitro could later be conducted in-vivo as a means to reduce the              
virulence of the carcinoma. Previous studies show that 2-methoxyestradiol induces tumor apoptosis            
and  has  anti-inflammatory  properties,  [1] .  
 
Image  1.0:  pBABE  Plasmid  Map  (Snapgene) 
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III.  Materials  and  Methods 
 
Transfection  1:  pBABE-PEI  JET  Variations  with  Low  Ratios 
I thawed a vile of TOV-112 ovarian cancer cells frozen from 04/2017 with a passage number of 36                  
on a 100-mL cell culture plate and grew/transferred the cells until five passages have passed. Each                
cell culture plate had 12-mL of 90%DMEM, 10%FBS, and 0.5% Penstrep media. In each passage,               
cells grew for 48-72 hours (until 100% confluence). Passage 41 TOV-112 cells were transferred to               
a 6-well plate with a cell count of 7.0x10^5 cells/mg and 2-mL of 90% DMEM, 10%FBS, and                 
0.5% Penstrep media in each well. In five-1mL conical tubes, I mixed 200-μL Optimem Media;               
1.0-μg, 1.25-μg, 1.5-μg, 1.75-μg, and 2-μg pBABE (0.47μg/μL concentration) respectively, and           
6.0μg of vortexed PEI-JET (1.0μg/μL concentration). Each 1-mL conical tube was vortexed every             
five minutes for fifteen minutes at T 0min, 5min, 10min, and 15min. The 90% DMEM, 10% FBS,                 
and 0.5% Penstrep media was replaced with 90%DMEM and 10% FBS media in each well               
(2-mL). The pBABE mixtures were added to wells 1-5 respectively, leaving well 6 as the control.                
The cells grew for 48 total hours with observations under a compound microscope to see the                
fluorescence  at  T-24hours  and  T-48hours.  
 
Transfection  2:  Initial  Cell  Count  Variations 
I transferred the 100-mL cell culture plate of P43 TOV-112 cells from my maintained cell line to a                  
6-well cell culture plate. Initial cell counts were 6.0x10^5, 6.5x10^5, 7.0x10^5, 7.5x10^5, and             
8.0x10^5 cells/mg respectively in wells 1-5. The control in well 6 was plated with 7.0x10^5-the               
average of all experimental values. Each well had 2-mL of 90%DMEM, 10%FBS, and             
0.5%Penstrep media. In five 1-mL conical tubes, I mixed 200-μL Optimem Media, 2-μg pBABE              
(concentration 0.47 μg/μL), and 6-μg of vortexed PEI-JET (1.0 μg/μL concentration). Each 1-mL             
conical tube was vortexed every five minutes for fifteen minutes at T 0min, 5min, 10min, and                
15min. The 90% DMEM, 10% FBS, and 0.5%Penstrep media was replaced with 90%DMEM and              
10% FBS media in each well (2-mL). The pBABE mixtures were added to wells 1-5 respectively,                
leaving well 6 as the control. The cells grew for 48 total hours with observations under a                 
compound  microscope  to  see  the  fluorescence  at  T-24hours  and  T-48hours.  
 
Transfection  3:  Initial  Cell  Count  Variation 
I transferred the 100-mL cell culture plate with P47 TOV-112 cells from my maintained cell line to                 
a 6-well cell culture plate. Initial cell counts were 6.5x10^3 (in wells 1 and 4), 6.5x10^4 (wells 2                  
and 5), and 6.5x10^5 (wells 3 and 6) cells/mg. Wells 4, 5 and 6 were used as controls. Each well                    
had 2-mL of 90%DMEM, 10%FBS, and 0.5%Penstrep media. In three 1-mL conical tubes, I              
mixed 200-μL Optimem Media, 2-μg pBABE (concentration 0.811 μg/μL), and 6-μg of vortexed             
PEI-JET (1.0 μg/μL concentration). Each 1-mL conical tube was vortexed every five minutes for              
fifteen minutes at T 0min, 5min, 10min, and 15min. The 90% DMEM, 10% FBS, and               
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0.5%Penstrep media was replaced with 90%DMEM and 10% FBS media in each well (2-mL).              
The pBABE mixtures were added to wells 1-3, respectively, leaving well 4, 5, and 6 as the                 
controls. The cells grew for 48 total hours with observations under a compound microscope to see                
the  fluorescence  at  T-24hours  and  T-48hours.  
 
Transfection  4:  pBABE-PEI  JET  Variations 
The passage 51 TOV-112 cells were transferred to a 6-well plate with a cell count of 3.0x10^5                 
cells/mg and 2-mL of 90% DMEM, 10%FBS, and 0.5%Penstrep media in each well. In three-1mL               
conical tubes, I mixed 200-μL Optimem Media; 3.0-μg, 2.0-μg, 1.0-μg pBABE (0.811 μg/μL             
concentration), respectively, and 6.0μg of vortexed PEI-JET (1.0μg/μL concentration). Each 1-mL           
conical tube was vortexed every five minutes for fifteen minutes at T 0min, 5min, 10min, and                
15min. The 90% DMEM, 10% FBS, and 0.5%Penstrep media was replaced with 90%DMEM and              
10% FBS media in each well (2-mL). The pBABE mixtures were added to wells 1-3 respectively,                
leaving wells 4, 5, and 6 as the controls. The cells grew for 48 total hours with observations under                   
a  compound  microscope  to  see  the  fluorescence  at  T-24hours  and  T-48hours.  
 
 
IV.  Results 
 
Transfection  1:  pBABE/PEI  JET  Ratio  Variations 
 
Results show an increase number of pBABE transfected TOV-112 cells with lower pBABE/PEI             
JET ratios. There is also increased expansion with the fluorescent cells and limited patched              
transfection areas that are prevalent with the lower concentration ratios. Transfected cells are             
indicated by the bright green areas in the first column. The second column shows the brightfield                
image  at  that  time.  
 
 
Figure  1.1:  Results  at  24  Hours 
 
            1:6                           1.25:6                           1:4                            1.75:6                          1:3 
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Figure  1.2:  Results  at  48  Hours 
 
            1:6                            1.25:6                           1:4                           1.75:6                          1:3 
  
 
 
 
 
 
 
 
 
 
 
Transfection  2:  Initial  Cell  Count  Variations 
 
There is an increase in positive transfected cells with the initial cell count of 6.5x10^5 cells/μg.                
Though it shows the most success, there is still a very limited number of positive transfections in                 
each well. Transfected cells are indicated by the bright green areas in the first column. The second                 
column  shows  the  brightfield  image  at  that  time. 
 
 
Figure  2.1:  Results  at  24  Hours 
 
     6.0x10^5                 6.5x10^5                   7.0x10^5                    7.5x10^5                 8.0x10^5 
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Figure  2.2:  Results  at  48  Hours 
 
    6.0x10^5                 6.5x10^5                   7.0x10^5                    7.5x10^5                 8.0x10^5 
 
 
 
 
 
 
 
 
 
 
 
Transfection  3:  Initial  Cell  Count  Variations 
 
The Results below show wells seeded with low initial cell counts. This was in attempt to combat                 
the excessive confluency and cell death from the previous transfections. There is a very limited               
number of successful transfected cells and little variation between the three experimental wells. I              
used “6.5” since it previously showed a greater number of transfected cells in Transfection 2.               
Transfected cells are indicated by the bright green areas in the first column. The second column                
shows  the  brightfield  image  at  that  time. 
 
 
 
Figure  3.1:  Results  at  24  Hours 
 
                        6.5x10^3                                 6.5x10^4                               6.5x10^5 
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Figure  3.2:  Results  at  48  Hours 
 
   6.5x10^3                                 6.5x10^4                               6.5x10^5 
 
 
 
 
 
 
 
 
 
 
 
 
Transfection  4:  pBABE/PEI  JET  Variation  with  Low  Ratios 
 
The final transfection, again, varied the ratio of pBABE and PEI JET in attempt to visualize                
whether or not a lower ratio constitutes a greater successful output. I cut the previously successful                
initial cell count to 3x10^5 in attempt to, again, counteract the initial cell death that occurs at high                  
levels of confluency. There were three experimental wells with 1:6, 1:3, and 1:2 pBABE/PEI JET               
ratios respectively. Transfected cells are indicated by the bright green areas in the first column. The                
second  column  shows  the  brightfield  image  at  that  time. 
 
 
 
Figure  4.1:  Results  at  24  Hours 
 
                           1:6                                            1:3                                            1:2 
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Figure  4.2:  Results  at  48  Hours 
 
   1:6                                            1:3                                            1:2 
 
 
 
 
 
 
 
 
 
 
 
V.  Discussion 
 
PEI-JET and pBABE ratios show a drastic difference in transfection efficiency since the Green              
Fluorescent Protein utilizes PEI-JET for its genetic deliverance. Results show that lower ratios             
promote successful transfections, indicated by the increased level of green fluorescence cells. Initial             
cell count plays a secondary role in transfection success with the TOV-112 cells. In the comparison                
of transfection 2 with transfection 3, though high levels of initial cell count resulted in a greater                 
incidence of cell death at the 48 hour mark, vastly decreasing the original plate seeding resulted in                 
confluence that was not optimal for success. With a low pBABE/PEI JET ratio and a slight                
decrease in original seeding to 3x10^5 cells/mg (reaching 100% confluency by 24 hours), there              
was an elevation in pBABE-transfected TOV-112 ovarian cancer cells. Thus, in responding to the              
initial thesis question and in hopes to regulate the transfection procedure for this type of carcinoma                
cell line, the results illustrate that success correlates with a low pBABE/PEI JET ratio and an initial                 
cell count around 3x10^5 cells/mg. A revised procedure that take these results into account is as                
follows: 
Grow TOV-112 ovarian cancer cells to 80% confluency on a 100-mL cell culture             
plate in 12-mL of 90% DMEM, 10% FBS, and 0.5% Penstrep media. Seed a              
6-well plate with an initial cell count of 3x10^5 cells/mg. Add 2-mL of the 90%               
DMEM, 10% FBS, and 0.5% Penstrep media to each well. Incubate the cells for 24               
hours. At this mark, add 200-μL of Optimem media, 6-μg vortexed PEI-JET, and             
3-μg of pBABE in a 1.5-mL conical tube. Repeat this for each experimental well.              
Vortex each tube for 10-seconds at T-0min, 5min, 10min, and 15min. Carefully            
replace the present media in the 6-well plate with 2-mL of 90% DMEM and 10%               
FBS in each well. Add the conical tube mixtures to their respective wells. Carefully              
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move the plate to swirl the mixture and incubate. Observe the cells at 24 and 48                
hours.  
While the experiments were successful in formulating a more accurate transfection procedure for             
TOV-112 cells, more transfection repeats could have been conducted for better result accuracy.             
Future work will focus on this repetition and utilize the detailed transfection procedure. Possible              
errors in experimentation may include working with two different concentrations of pBABE and             
therefore having a lack of control. Despite the different concentrations, however, calculations            
accounted for the variation. With this resulting information, there may be future experiments             
working with pBABE/MetLuc transfections with the introduction of 2-methoxyestradiol. MetLuc          
is an plasmid that contains the luciferase gene. This gene is under control by the NFkB promoter.                 
NFkB is a transcription factor that is stimulated in response to cellular stress. Increased activity is                
correlated with increased inflammatory response. Ovulation, essentially, is an inflammatory          
process. If 2-methoxy attracts anti-inflammatory factors, the ovarian cancer over-inflammation          
stimulated by NFkB, may be reduced. 2-methoxyestradiol is a natural metabolite of estrogen. By              
co-transfecting the TOV-112 cells with pBABE and MetLuc, we can measure transfection            
efficiency. Using a Luciferase protein assay, the amount of NFkB activity on TOV-112 cells can be                
studied, since NFkB response is proportional to Luciferase activity. Introducing 2-methoxyestradiol           
to the cell plate allows for the analysis of its anti-inflammatory action on the ovarian cancer cells by                  
observing the difference of NFkB activity over time. In conclusion, this study is a necessary step                
for larger ovarian cancer research and the regulation of this procedure will help to diminish               
possible  errors  with  further  experimentation.  
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VII.  Calculations  
 
Transfection  1 
248  cells  x  ⅖  x  10,000  =  9.92x10^5cells/1mL  x  7x10^5cells/1mL  =  70.6μL  cell  suspension/well 
2.0  μL  pBABE  x  0.47  μg/μL  pBABE  =  1.0  μg  pBABE 
2.5  μL  pBABE  x  0.47  μg/μL  pBABE  =  1.25  μg  pBABE 
3.0  μL  pBABE  x  0.47  μg/μL  pBABE  =  1.5  μg  pBABE 
3.5  μL  pBABE  x  0.47  μg/μL  pBABE  =  1.75  μg  pBABE 
4.0  μL  pBABE  x  0.47  μg/μL  pBABE  =  2.0  μg  pBABE 
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Transfection  2 
576  cells  x  ⅖  x  10,000  =  2.3  x  10^6  cells/mL 
2.3x10^6  cells/mL  =  6.0x10^5  =  0.261  mL  cell  suspension/well 
2.3x10^6  cells/mL  =  6.5x10^5  =  0.283  mL  cells  suspension/well 
2.3x10^6  cells/mL  =  7.0x10^5  =  0.304  mL  cell  suspension/well 
2.3x10^6  cells/mL  =  7.5x10^5  =  0.326  mL  cell  suspension/well 
2.3x10^6  cells/mL  =  8.0x10^5  =  0.348  mL  cell  suspension/well 
 
Transfection  3 
357  cells  x  ⅖  10,000  =  1.43x10^6  cells/mL 
1.43x10^6  cells/mL  =  6.5x10^3  =  4.5  μL  cell  suspension/well 
1.43x10^6  cells/mL  =  6.5x10^4  =  45  μL  cell  suspension/well 
1.43x10^6  cells/mL  =  6.5x10^5  =  450  μL  cell  suspension/well 
0.811  μg/μL  pBABE  x  “x”  =  2.0  μg/μL  =  2.5  μL  pBABE 
 
Transfection  4 
304  cells  x  ⅖  x  10,000  =  1.22x10^6  cells/mL  x  3x10^5  cells/mL  =  0.247  mL  cell  suspension/well 
0.811  μg/μL  pBABE  =  3  μg/X  μL  =  3.7  μL  pBABE 
0.811  μg/μL  pBABE  =  2  μg/X  μL  =  2.5  μL  pBABE 
0.811  μg/μL  pBABE  =  1  μg/X  μL  =  1.2  μL  pBABE 
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